510(k) K033908

N HIGH SENSITIVITY CRP by Dade Behring, Inc. — Product Code NQD

K033908 is an FDA 510(k) premarket notification submitted by Dade Behring, Inc. for the device "N HIGH SENSITIVITY CRP". The FDA issued a decision of Substantially Equivalent on Jan 22, 2004. The device falls under product code NQD (Cardiac C-Reactive Protein, Antigen, Antiserum, And Control), a Class II device regulated under 21 CFR 866.5270. Dade Behring, Inc. has 342 other 510(k) clearances on record.

Clearance details

Decision
SESE (Substantially Equivalent)
Decision Date
Jan 22, 2004
Date Received
Dec 17, 2003
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device classification

Device Name
Cardiac C-Reactive Protein, Antigen, Antiserum, And Control
Device Class
Class II
Regulation Number
866.5270
Review Panel
IM
Submission Type
510(k)

In vitro diagnostic test to measure C-reactive protein for the purpose of making cardiac risk assessments.

Need the full FDA record for Dade Behring, Inc.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: FDA 510(k) database entry for K033908. Report a data issue: hello@regdatalab.com.